CH616160A5 - Process for the preparation of novel compounds which affect gastric acid secretion - Google Patents

Process for the preparation of novel compounds which affect gastric acid secretion Download PDF

Info

Publication number
CH616160A5
CH616160A5 CH182975A CH182975A CH616160A5 CH 616160 A5 CH616160 A5 CH 616160A5 CH 182975 A CH182975 A CH 182975A CH 182975 A CH182975 A CH 182975A CH 616160 A5 CH616160 A5 CH 616160A5
Authority
CH
Switzerland
Prior art keywords
benzimidazole
pyridylmethylthio
hydrogen
formula
het
Prior art date
Application number
CH182975A
Other languages
German (de)
English (en)
Inventor
Peder Bernhard Berntsson
Stig Ake Ingemar Carlsson
Lars Erik Garberg
Ulf Krister Junggren
Sven Erik Sjoestrand
Gunhild Wika Von Wittk Sundell
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CH616160A5 publication Critical patent/CH616160A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
CH182975A 1974-02-18 1975-02-14 Process for the preparation of novel compounds which affect gastric acid secretion CH616160A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7402101A SE418966B (sv) 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Publications (1)

Publication Number Publication Date
CH616160A5 true CH616160A5 (en) 1980-03-14

Family

ID=20320233

Family Applications (1)

Application Number Title Priority Date Filing Date
CH182975A CH616160A5 (en) 1974-02-18 1975-02-14 Process for the preparation of novel compounds which affect gastric acid secretion

Country Status (23)

Country Link
JP (1) JPS5924157B2 (nl)
AT (1) AT343659B (nl)
AU (1) AU499639B2 (nl)
BE (1) BE825655A (nl)
CA (1) CA1060448A (nl)
CH (1) CH616160A5 (nl)
CS (1) CS194715B2 (nl)
DD (1) DD119422A5 (nl)
DE (1) DE2504252A1 (nl)
DK (1) DK141122B (nl)
FI (1) FI59590C (nl)
FR (1) FR2261007B1 (nl)
GB (1) GB1500043A (nl)
HK (1) HK67080A (nl)
HU (1) HU172141B (nl)
IE (1) IE40858B1 (nl)
LU (1) LU71872A1 (nl)
MY (1) MY8100208A (nl)
NL (1) NL7501917A (nl)
NO (1) NO142401C (nl)
SE (1) SE418966B (nl)
SU (1) SU795476A3 (nl)
ZA (1) ZA75558B (nl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
JPS5364103A (en) * 1976-09-24 1978-06-08 Hitachi Ltd Waste heat recovery boiler
IN148930B (nl) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3047388A1 (de) * 1980-12-16 1982-07-15 Basf Ag, 6700 Ludwigshafen Isatogenderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US4503139A (en) * 1983-05-09 1985-03-05 Polaroid Corporation Photographic products and processes and novel compounds
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
US4767770A (en) * 1984-06-18 1988-08-30 Eli Lilly And Company Method of inhibiting aromatase
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
JPH021280U (nl) * 1988-06-14 1990-01-08
WO1990003373A1 (en) * 1988-09-20 1990-04-05 Hisamitsu Pharmaceutical Co., Inc. NOVEL DIBENZ[b,e]OXEPIN DERIVATIVES
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
JP2679745B2 (ja) * 1989-06-29 1997-11-19 明治製菓株式会社 アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
JPH0347053U (nl) * 1989-09-16 1991-04-30
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
IL163625A0 (en) * 2002-03-27 2005-12-18 Altana Pharma Ag Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
DE602004002464T2 (de) 2003-02-25 2007-10-04 Altana Pharma Ag Imidazo[4,5-b]chinolinderivate und ihre Verwendung als Inhibitoren der induzierbaren NO-Synthase
EP1675853B1 (en) * 2003-10-01 2008-06-18 Nycomed GmbH Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
ATE399168T1 (de) 2003-10-01 2008-07-15 Nycomed Gmbh Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
AU2004276013A1 (en) * 2003-10-01 2005-04-07 Altana Pharma Ag Imidazopyridine-derivatives as inducible no-synthase inhibitors
BRPI0414972A (pt) 2003-10-01 2006-11-07 Altana Pharma Ag derivados de imidazopiridinas como inibidores de no-sintase induzìvel
RS20060206A (en) * 2003-10-01 2008-08-07 Altana Pharma Ag., Aminopyridine-derivatives as inducible no-synthase inhibitors
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
EP3318561B1 (en) * 2010-05-26 2021-12-22 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (nl) * 1968-10-21 1971-06-03

Also Published As

Publication number Publication date
FR2261007A1 (nl) 1975-09-12
CS194715B2 (en) 1979-12-31
JPS5924157B2 (ja) 1984-06-07
LU71872A1 (nl) 1975-12-09
NO142401C (no) 1980-08-13
FR2261007B1 (nl) 1978-11-24
MY8100208A (en) 1981-12-31
AU499639B2 (en) 1979-04-26
HU172141B (hu) 1978-06-28
BE825655A (fr) 1975-08-18
DE2504252A1 (de) 1975-08-21
SE7402101L (nl) 1975-08-19
NO142401B (no) 1980-05-05
NO750541L (nl) 1975-08-19
FI750421A (nl) 1975-08-19
DD119422A5 (nl) 1976-04-20
CA1060448A (en) 1979-08-14
ZA75558B (en) 1976-01-28
AT343659B (de) 1978-06-12
IE40858L (en) 1975-08-18
HK67080A (en) 1980-12-05
FI59590B (fi) 1981-05-29
ATA113775A (de) 1977-10-15
GB1500043A (en) 1978-02-08
DK54075A (nl) 1975-10-20
DE2504252C2 (nl) 1989-02-02
SU795476A3 (ru) 1981-01-07
IE40858B1 (en) 1979-08-29
AU7820675A (en) 1976-08-19
JPS50116474A (en) 1975-09-11
FI59590C (fi) 1981-09-10
DK141122C (nl) 1980-07-07
NL7501917A (nl) 1975-08-20
DK141122B (da) 1980-01-21
SE418966B (sv) 1981-07-06

Similar Documents

Publication Publication Date Title
CH616160A5 (en) Process for the preparation of novel compounds which affect gastric acid secretion
DE2548340C2 (nl)
EP0001279B1 (de) Imidazolderivate deren Herstellung und diese enthaltende Präparate
EP0542059B1 (de) Substituierte Biphenylpyridone als Angiotensin II Antagonisten
DD142882A5 (de) Verfahren zur herstellung von pyridylmethylsulfinylbenzimidazolen
DE4206045A1 (de) Sulfonylbenzyl substituierte pyridone
DD202876A5 (de) Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen
DE4316077A1 (de) Substituierte Mono- und Bihydridylmethylpyridone
EP0569795B1 (de) Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
EP0610698B1 (de) Substituierte Imidazo(4,5-b)pyridine und Benzimidazole als Angiotensin II Antagoniste
DE4215588A1 (de) Biphenylmethyl-substituierte Pyridone
DE4132631A1 (de) Imidazolyl-propensaeurederivate
EP0608709A1 (de) 2-Oxochinolin-l-yl-methyl-phenylessigsäurederivate als Angiotensin II Antagonisten
EP0630896A1 (de) Substituierte Mono- und Bipyridylmethylderivate als Angiotensin II Antagonist
DE4302957A1 (de) Imidazolyl-substituierte Phenylessigsäureprolinamide
EP0581003B1 (de) Imidazolyl-substituierte Cyclohexanderivate
DE4309968A1 (de) Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
EP0138034B1 (de) Substituierte Pyrido(1,2-c)imidazo((1,2-a)benzimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE2605824C3 (de) N-Acylaniline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE4206041A1 (de) Sulfonylbenzyl-substituierte imidazolylpropensaeurederivate
AT374472B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
CH654575A5 (de) Antiarhythmisch wirksame phenaethylpiperidin-verbindungen.
AT374473B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
EP0048363B1 (de) Imidazolderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie diese enthaltende Arzneimittel
AT406119B (de) Verfahren zur herstellung von granulaten bzw. tabletten oder kapseln zur oralen verabreichung

Legal Events

Date Code Title Description
PL Patent ceased